TY - JOUR
T1 - Establishment of reporter cells that respond to glucocorticoids by a transposon-mediated promoter-trapping system
AU - Ishikawa, Kosuke
AU - Tamamura, Sakura
AU - Semba, Kentaro
AU - Watanabe, Shinya
N1 - Funding Information:
We are grateful to Drs. Allan Bradley and Kosuke Yusa (the Wellcome Trust Sanger Institute) for providing the backbone donor vectors for the piggyBac transposon and the hyPBase vector. We also thank Jiro Fujimoto for extensive discussions, Kumiko Semba for secretarial assistance, and Enago (https://www.enago.jp) for editing the English language of this paper. This study was supported by the translational research programs from Fukushima Prefecture.
Funding Information:
This study was supported by the translational research programs from Fukushima Prefecture.
Publisher Copyright:
© 2021
PY - 2021/7/1
Y1 - 2021/7/1
N2 - Previously, we had established a highly sensitive trap vector system for the efficient isolation of reporter cells for a certain condition of interest. In this study, we used this system to screen reporter cells that express the luciferase and enhanced green fluorescent protein genes in response to dexamethasone, a glucocorticoid receptor agonist to facilitate glucocorticoid signaling research. In total, 10 clones were isolated. The insertion sites of the trap vector were analyzed using 5′ rapid amplification of cDNA ends (5′ RACE), whereupon LPIN1, PKP2, and FKBP5 were identified as genes that were upregulated by the dexamethasone treatment. Specifically, PKP2 has not previously been focused as a gene that responds to glucocorticoids. The PKP2 mRNA was analyzed and induction of the endogenous gene was confirmed by real-time polymerase chain reaction. Given that PKP2 does not appear to have a consensus glucocorticoid response element (GRE) sequence, this reporter clone could supplement the current GRE-based reporter systems that are prevalently used. Because different clones showed different responses to glucocorticoids, these clones should provide more information than analysis with a single reporter clone. This paper demonstrates that the previously developed trap vector technology can contribute to the rapid construction of drug evaluation systems.
AB - Previously, we had established a highly sensitive trap vector system for the efficient isolation of reporter cells for a certain condition of interest. In this study, we used this system to screen reporter cells that express the luciferase and enhanced green fluorescent protein genes in response to dexamethasone, a glucocorticoid receptor agonist to facilitate glucocorticoid signaling research. In total, 10 clones were isolated. The insertion sites of the trap vector were analyzed using 5′ rapid amplification of cDNA ends (5′ RACE), whereupon LPIN1, PKP2, and FKBP5 were identified as genes that were upregulated by the dexamethasone treatment. Specifically, PKP2 has not previously been focused as a gene that responds to glucocorticoids. The PKP2 mRNA was analyzed and induction of the endogenous gene was confirmed by real-time polymerase chain reaction. Given that PKP2 does not appear to have a consensus glucocorticoid response element (GRE) sequence, this reporter clone could supplement the current GRE-based reporter systems that are prevalently used. Because different clones showed different responses to glucocorticoids, these clones should provide more information than analysis with a single reporter clone. This paper demonstrates that the previously developed trap vector technology can contribute to the rapid construction of drug evaluation systems.
KW - Gene reporter assay
KW - Glucocorticoid receptor
KW - Glucocorticoids
KW - Transposon
KW - Trap vector
UR - http://www.scopus.com/inward/record.url?scp=85103715675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103715675&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2021.105819
DO - 10.1016/j.ejps.2021.105819
M3 - Article
C2 - 33775826
AN - SCOPUS:85103715675
SN - 0928-0987
VL - 162
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
M1 - 105819
ER -